<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dk.um.si/IzpisGradiva.php?id=99059"><dc:title>Koristi in pasti zdravljenja s SGLT-2 zaviralci</dc:title><dc:creator>Forštnarič,	Alex	(Avtor)
	</dc:creator><dc:creator>Stajan,	Ana	(Avtor)
	</dc:creator><dc:creator>Piko,	Nejc	(Avtor)
	</dc:creator><dc:subject>botulinum toxin type A</dc:subject><dc:subject>SGLT2 inhibitors</dc:subject><dc:subject>type 2 diabetes</dc:subject><dc:subject>chronic kidney disease</dc:subject><dc:subject>heart failure</dc:subject><dc:subject>clinical outcomes</dc:subject><dc:publisher>MF UM</dc:publisher><dc:date>2026</dc:date><dc:date>2026-07-29 03:06:19</dc:date><dc:type>Znanstveno delo</dc:type><dc:identifier>99059</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>